Compile Data Set for Download or QSAR
Report error Found 8 of ic50 for monomerid = 156394
TargetBcl-2-like protein 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 18 | US9018381, 17 | US9248140, 18)
Affinity DataIC50: 1nMAssay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of kno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2015
Entry Details
Go to US Patent

TargetBcl-2-like protein 1 [1-209](Human)
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 18 | US9018381, 17 | US9248140, 18)
Affinity DataIC50: 1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 18 | US9018381, 17 | US9248140, 18)
Affinity DataIC50: 2nMAssay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of kno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2015
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 18 | US9018381, 17 | US9248140, 18)
Affinity DataIC50: 2nMAssay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of kno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2015
Entry Details
Go to US Patent

TargetBcl-2-like protein 1 [1-209](Human)
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 18 | US9018381, 17 | US9248140, 18)
Affinity DataIC50: 2nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2 [1-204](Human)
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 18 | US9018381, 17 | US9248140, 18)
Affinity DataIC50: 2nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2(Human)
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 18 | US9018381, 17 | US9248140, 18)
Affinity DataIC50: 7nMAssay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of kno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2015
Entry Details
Go to US Patent

TargetApoptosis regulator Bcl-2 [1-204](Human)
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 18 | US9018381, 17 | US9248140, 18)
Affinity DataIC50: 7nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent